AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology (NASDAQ: AFJK) announced it has terminated its Business Combination Agreement with United Hydrogen Group.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Aimei Health Technology (NASDAQ: AFJK) announced it has terminated its Business Combination Agreement with United Hydrogen Group. The agreement, originally signed June 19, 2024 and amended June 6, 2025, was ended effective July 7, 2026 after passing the contractual outside date without closing.
According to the company, leadership remains focused on identifying and executing another potential transaction and expressed appreciation for United Hydrogen’s efforts during the process.
Positive
- Termination frees AFJK to pursue alternative business combination opportunities
- Management reiterates intention to identify and execute a future transaction
Negative
- Planned business combination with United Hydrogen will not be completed
- Uncertainty remains around timing and terms of any future transaction
Details
Market move: AFJK -51.70% in the Jul 9 session. United Hydrogen merger termination
On Jul 9, the first trading day after this news, AFJK closed 51.70% below the previous close. Argus tracked a peak move of +3.7% during that session. Argus tracked a trough of -5.7% from its starting point during tracking. Our momentum scanner recorded 8 alerts for this stock that day. Relative volume reached 24.9x the daily average during tracking.
Data tracked by StockTitan Argus for the Jul 9 session.
Key Figures
- Agreement date
- June 19, 2024
- Business Combination Agreement with United Hydrogen
- Amendment date
- June 6, 2025
- Amendment to Business Combination Agreement
- Termination notice date
- July 7, 2026
- Notice of termination delivered to United Hydrogen
Historical Context
-
Nasdaq notification for missing Form 10-Q filing deadline for March 31, 2026.
-
Nasdaq notice for late Form 10-K filing and grant of cure period to regain compliance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
business combination agreement financial
outside date regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto.
The Company delivered a notice of termination to United Hydrogen on July 7, 2026, pursuant to Section 9.1(b) of the Business Combination Agreement, effective immediately. The termination was triggered by the occurrence of the applicable outside date, as the closing of the proposed business combination was not consummated on or prior to such date.
Xie Junheng, Chief Executive Officer and Director of the Company, stated, “Although we were unable to complete the proposed business combination with United Hydrogen within the required timeframe, we remain confident in our ability to identify and execute a compelling transaction in the future. We thank the United Hydrogen team for their efforts and professionalism throughout the process.”
Contact:
Xie Junheng
Aimei Health Technology Co., Ltd
10 East 53rd Street, Suite 3001
New York, NY 10022
Email: Xiejunheng@aimeihealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.